Bromazepam
Side effects
Options:
Hide MedDRA Preferred Terms
|
MedDRA Preferred Term
|
Side effect
|
Data for drug
|
Placebo
|
Labels
|
|
|
1
|
2
|
|
Somnolence
|
Drowsiness
|
postmarketing, 32%
|
|
x
|
x
|
|
Ataxia
|
Ataxia
|
postmarketing, 13%
|
|
x
|
x
|
|
Dizziness
|
Dizziness
|
postmarketing, 7.6%
|
|
x
|
x
|
|
Speech disorder
|
Speech disorder
|
postmarketing, 2%
|
|
|
x
|
|
Dyspepsia
|
Digestion impaired
|
1%
|
|
x
|
x
|
|
Gastrointestinal disorder
|
Digestion impaired
|
1%
|
|
x
|
x
|
|
Gastrointestinal disorder
|
postmarketing
|
|
|
x
|
|
Confusional state
|
Confusional state
|
postmarketing, 1%
|
|
x
|
x
|
|
Feeling abnormal
|
Confusional state
|
postmarketing, 1%
|
|
x
|
x
|
|
Headache
|
Headache
|
postmarketing, 1%
|
|
x
|
x
|
|
Nausea
|
Nausea
|
postmarketing, 1%
|
|
x
|
x
|
|
Vomiting
|
Vomiting
|
postmarketing, 1%
|
|
x
|
x
|
|
Sleep disorder
|
Sleep disorder
|
postmarketing, 1%
|
|
|
x
|
|
Aggression
|
Aggression
|
postmarketing
|
|
x
|
x
|
|
Anger
|
Anger
|
postmarketing
|
|
x
|
x
|
|
Decreased appetite
|
Anorexia
|
postmarketing
|
|
|
x
|
|
Mental disorder
|
Mental disorder
|
postmarketing
|
|
|
x
|
|
Connective tissue disorder
|
Connective tissue disorder
|
postmarketing
|
|
|
x
|
|
Delusion
|
Delusion
|
postmarketing
|
|
x
|
x
|
|
Diplopia
|
Diplopia
|
postmarketing
|
|
x
|
x
|
|
Emotional disorder
|
Emotional disturbance NOS
|
postmarketing
|
|
|
x
|
|
Emotional disorder
|
|
|
x
|
|
|
Dermatitis
|
Rash
|
postmarketing
|
|
x
|
x
|
|
Rash
|
Rash
|
postmarketing
|
|
x
|
x
|
|
Eye disorder
|
Eye disorder
|
postmarketing
|
|
|
x
|
|
Asthenia
|
Fatigue
|
postmarketing
|
|
x
|
x
|
|
Fatigue
|
Fatigue
|
postmarketing
|
|
x
|
x
|
|
Multiple fractures
|
Fracture
|
postmarketing
|
|
x
|
x
|
|
Fracture
|
Fracture
|
postmarketing
|
|
x
|
x
|
|
Hallucination
|
Hallucination
|
postmarketing
|
|
x
|
x
|
|
Cardiac arrest
|
Cardiac arrest
|
postmarketing
|
|
x
|
x
|
|
Cardiac disorder
|
Cardiac disorder
|
postmarketing
|
|
|
x
|
|
Cardiac failure
|
Cardiac failure
|
postmarketing
|
|
x
|
x
|
|
Hypotension
|
Hypotension
|
postmarketing
|
|
x
|
x
|
|
Incontinence
|
Incontinence
|
postmarketing
|
|
x
|
x
|
|
Irritability
|
Irritability
|
postmarketing
|
|
x
|
x
|
|
Nervous system disorder
|
Nervous system disorder
|
postmarketing
|
|
|
x
|
|
Nervousness
|
Nervousness
|
postmarketing
|
|
|
x
|
|
Tension
|
Nervousness
|
postmarketing
|
|
|
x
|
|
Nightmare
|
Nightmare
|
postmarketing
|
|
x
|
x
|
|
Palpitations
|
Palpitations
|
postmarketing
|
|
x
|
x
|
|
Pruritus
|
Pruritus
|
postmarketing
|
|
x
|
x
|
|
Psychotic disorder
|
Psychotic disorder
|
postmarketing
|
|
x
|
x
|
|
Convulsion
|
Convulsion
|
postmarketing
|
|
x
|
x
|
|
Muscle spasms
|
Muscle spasms
|
postmarketing
|
|
x
|
x
|
|
Tachycardia
|
Tachycardia
|
postmarketing
|
|
x
|
x
|
|
Tremor
|
Tremor
|
postmarketing
|
|
|
x
|
|
Dry mouth
|
Dry mouth
|
postmarketing
|
|
x
|
x
|
|
Agitation
|
Agitation
|
postmarketing
|
|
|
x
|
|
Excitability
|
|
|
x
|
|
|
Muscular weakness
|
Muscular weakness
|
postmarketing
|
|
x
|
x
|
|
Haemoglobin decreased
|
Haemoglobin decreased
|
postmarketing
|
|
x
|
x
|
|
Malnutrition
|
Malnutrition
|
postmarketing
|
|
x
|
x
|
|
Skin disorder
|
Unspecified disorder of skin and subcutaneous tissue
|
postmarketing
|
|
x
|
x
|
|
Anterograde amnesia
|
Anterograde amnesia
|
postmarketing
|
|
x
|
x
|
|
Respiratory depression
|
Respiratory depression
|
postmarketing
|
|
x
|
x
|
|
Pulmonary function test decreased
|
Respiratory depression
|
postmarketing
|
|
x
|
x
|
|
Vision blurred
|
Vision blurred
|
postmarketing
|
|
x
|
x
|
|
Depressed level of consciousness
|
Alertness decreased
|
postmarketing
|
|
x
|
x
|
|
Anaphylactic shock
|
Anaphylactic shock
|
|
|
x
|
|
|
Hostility
|
Hostility
|
|
|
x
|
|
|
Hypersensitivity
|
Hypersensitivity
|
|
|
x
|
|
|
Euphoric mood
|
Euphoric mood
|
|
|
x
|
|
|
Blood glucose decreased
|
Blood glucose decreased
|
|
|
x
|
|
|
White blood cell count decreased
|
White blood cell count decreased
|
|
|
x
|
|
Indications
Information about indications was extracted from the indications and usage sections of the labels.
| Side effects: | 45 |
| Source: | Health Canada |
|---|
| Side effects: | 50 |
| Source: | medicines.org.au |
|---|
Color scheme:
standard – alternative
|
|
|
100%
|
|
|
|
75%
|
|
|
|
50%
|
|
|
|
10%
|
|
|
|
frequent (1% to 100%)
|
|
|
|
infrequent (0.1% to 1%)
|
|
|
|
rare (<0.1%)
|
|
|
|
postmarketing
|
|
|
|
0%
|
|
|
|
no frequency information
|
|
|
|
not found on label
|